Healthcare
Vertex Pharmaceuticals Incorporated (VRTX)
51/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $110.9B
- P/E
- 25.9
- Sector Median P/E
- 20.7
- F-Score
- 6/9
- ROIC
- 4.1%
- FCF Yield
- 3.3%
Tessera scores VRTX (Vertex Pharmaceuticals Incorporated) at 51/100 — top 50% of the Healthcare sector. VRTX trades at a P/E of 25.9, 25% above the sector median of 20.7. Piotroski F-Score is 6/9; trailing ROIC is 4.1%.
Sector Peers
- Regeneron Pharmaceuticals, Inc. (REGN)Mkt Cap: $74.2B · FCF: 27.9%
- Verona Pharma plc (VRNA)Mkt Cap: $72.7B · FCF: -43.6%
- argenx SE (ARGX)Mkt Cap: $49.7B · FCF: 12.0%
- Seagen Inc. (SGEN)Mkt Cap: $43.2B · FCF: -30.5%
- Alnylam Pharmaceuticals, Inc. (ALNY)Mkt Cap: $38.9B · FCF: 15.0%